Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.
利用疫苗接种减轻原始抗原罪，以增强针对 SARS-CoV-2 Omicron 亚型的广谱中和抗体反应
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70273
Zhang Guangxu, Wang Qian, Ji Kai, Wang Yuanzhou, Xu Wei, Zhou Jie, Liu Zezhong, Xiu Ruixue, Xing Lixiao, Zhou Jianghao, Shi Yuren, Lu Xishan, Wang Xuanyi, Ying Bo, Lu Lu, Jiang Shibo
